Bio-venture for Healthy Longevity and Anti-Aging from Kyoto University
Developing next-generation drugs for a healthy society with longevity
Latest news
Cyn-K Bio Inc. is committed to solving the challenges of a super-aging society through the development of next-generation medicine.
vision
Our mission is
to realize a healthy and long-lived society
Inflammation caused by cellular aging is known to be a trigger for many diseases.
We aim to realize a healthy society with longevity through the development of innovative medicines to treat diseases associated with aging.
Antibody drugs and vaccines
Some diseases associated with aging are due to the accumulation of unwanted substances produced by the body.
Antibody drugs treat disease by acting directly on these unwanted substances, neutralizing them or causing them to be eliminated from the body.
Vaccines are expected to prevent the accumulation of substances leading to disease by causing immune cells to store them in memory and produce antibodies.
Vaccines are expected to be developed for therapeutic purposes that act on substances produced in the body.
Our Technology and Approach
Antibody drugs to meet unmet medical needs Development of therapeutic vaccines using VLP technology
We are developing antibody drugs and therapeutic vaccines based on a global intellectual property strategy, with a focus on the research results of the Department of Dementia Control, Graduate School of Medicine, Kyoto University.
AI, IoT, Blockchain
The era of personalized medicine will begin with the application of the latest technologies
Through appropriate health monitoring and genome analysis, the body's condition is understood and data-driven treatments are provided